FDA Classifies Medtronic Voluntary February Recall for BioGlide Ventricular Snap Shun
Medtronic, Inc. announced that the U.S. Food and Drug Administration classified as Class I its voluntary recall action initiated on February 11, 2009 of its BioGlide Ventricular Snap Shunt Catheter (Cat. numbers 27782, 27708 and 27802) -- the cerebral ventricular catheter component of a shunt for the treatment of hydrocephalus.
The Following 2 Users Say Thank You to budget For This Useful Post:
Tags for this Thread